115 related articles for article (PubMed ID: 107356)
21. Effect of dextran on the fibrinolytic activity of urokinase.
Matsuo O; Kosugi T; Mihara H
Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):112-8. PubMed ID: 6180584
[No Abstract] [Full Text] [Related]
22. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
[TBL] [Abstract][Full Text] [Related]
23. [Chemosensitivity in established human bladder carcinoma and HELA cell lines in vitro].
Uchibayashi T
Nihon Hinyokika Gakkai Zasshi; 1983 Sep; 74(9):1606-20. PubMed ID: 6202921
[No Abstract] [Full Text] [Related]
24. [Enhanced cell killing by hyperthermia and irradiation in KK-47 cells (author's transl)].
Nakajima K
Nihon Hinyokika Gakkai Zasshi; 1980 Apr; 71(4):363-77. PubMed ID: 7401416
[No Abstract] [Full Text] [Related]
25. [Successful fibrinolytic treatment with urokinase six weeks after leg and pelvic vein thrombosis (author's transl)].
Trübestein G; Etzel F; Sobbe A
Dtsch Med Wochenschr; 1974 Nov; 99(48):2457-9. PubMed ID: 4448142
[No Abstract] [Full Text] [Related]
26. [Hyperthermic therapy of the bladder cancer. II. The kinetics of cell killing by hyperthermia plus bleomycin (author's transl)].
Kubota Y
Nihon Hinyokika Gakkai Zasshi; 1981 Jun; 72(6):735-41. PubMed ID: 6169866
[No Abstract] [Full Text] [Related]
27. [Combined use of heparin and urokinase in the patients with nephritis resistant to the conventional treatment and the significance of alpha 2-plasmin inhibitor in the therapy (author's transl)].
Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Shimizu K
Rinsho Ketsueki; 1982 Mar; 23(3):309-18. PubMed ID: 7050462
[No Abstract] [Full Text] [Related]
28. Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
Takada A; Takada Y
Thromb Res; 1982 Feb; 25(3):229-35. PubMed ID: 7038978
[TBL] [Abstract][Full Text] [Related]
29. Absorption and activity studies on intraluminal thio-tepa in the dog's bladder.
Cole DR; Howley T; Rowan R; Dreyer B; Tan YL; Gonzalez E; Rousselot LM
J Urol; 1965 Nov; 94(5):556-8. PubMed ID: 4954314
[No Abstract] [Full Text] [Related]
30. Combined intravesical therapy with doxorubicin (adriamycin) and urokinase in the management of superficial bladder tumours.
Khan O; Aherne GW; Williams G
Br J Urol; 1982 Jun; 54(3):280-2. PubMed ID: 7049304
[No Abstract] [Full Text] [Related]
31. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
[No Abstract] [Full Text] [Related]
32. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
Nocks BN; Nieh PT; Prout GR
J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
[TBL] [Abstract][Full Text] [Related]
33. [Own experiences with the treatment of papillomatous bladder neoplasms by intracystic administration of Thio-Tepa].
Dobrzecki W; Kaczmarek A
Pol Przegl Chir; 1977 Jun; 49(6a):743-8. PubMed ID: 407554
[No Abstract] [Full Text] [Related]
34. [Thio-Tepa in the chemotherapy and chemical prevention of papillary neoplasms of the bladder].
Delzotto L; Viggiano G; Marchini M; Barbui PE
Minerva Med; 1977 Jun; 68(28):1957-60. PubMed ID: 406584
[No Abstract] [Full Text] [Related]
35. [Thrombolytic therapy using urokinase: its mechanism and clinical use (author's transl)].
Sakuragawa N; Takahashi K
Rinsho Ketsueki; 1977 Jun; 18(6):726-31. PubMed ID: 916203
[No Abstract] [Full Text] [Related]
36. [Urokinase therapy in diabetic retinopathy (author's transl)].
Kojima K; Suzuki M; Ichikawa H; Ichikawa K; Torii F; Sato Y; Oguri T; Yamaguchi Y; Kobayashi M; Asanuma H
Nippon Ganka Gakkai Zasshi; 1981 Dec; 85(12):2108-14. PubMed ID: 7044071
[No Abstract] [Full Text] [Related]
37. Threshold phenomena in blood fibrinolysis.
Matsuo O; Mihara H
Thromb Res; 1977 May; 10(5):753-8. PubMed ID: 882961
[No Abstract] [Full Text] [Related]
38. Absorption studies on intraluminal thio-tepa for topical cytostatic treatment of low-stage bladder tumors.
Lunglmayr G; Czech K
J Urol; 1971 Jul; 106(1):72-4. PubMed ID: 4998357
[No Abstract] [Full Text] [Related]
39. [Effect of temperature, pH and thio-tepa on tumour take rates and thymidine incorporation in ascites tumour cells (author's transl)].
Euler J; Sauermann G; Priesching A; Klöckler K
Wien Klin Wochenschr; 1974 Apr; 86(8):211-9. PubMed ID: 4207090
[No Abstract] [Full Text] [Related]
40. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
